Détention brevets de la classe C40B 40/02

Brevets de cette classe: 596

Historique des publications depuis 10 ans

40
40
65
69
47
32
29
42
27
21
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Propriétaires principaux

Proprétaire
Total
Cette classe
Inscripta, Inc., FORMERLY Muse Biotechnology, Inc.
269
38
The Regents of the University of California
20842
20
Yale University
2562
8
Massachusetts Institute of Technology
10285
7
Adimab, LLC
156
7
The Governing Council of The University of Toronto,
1547
7
Immunocore Limited
244
7
48Hour Discovery Inc.
10
7
Genentech, Inc.
4119
6
Affinity Biosciences Pty Ltd
10
6
National Research Council of Canada
1549
6
The University of British Columbia
1549
6
President and Fellows of Harvard College
6110
5
CytomX Therapeutics, Inc.
233
5
The Governors of the University of Alberta
875
5
Nantbio, Inc.
146
5
Centre National de La Recherche Scientifique
11077
4
The Board of Trustees of the Leland Stanford Junior University
6697
4
Takeda Pharmaceutical Company Limited
2699
4
BioAtla, LLC
50
4
Autres propriétaires 435